Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
European Urology Focus|June 7, 2024
What About Variant Histologies in Bladder Cancer?Elizabeth Day, Javier Gavira, Jose C Tapia, et al.Clinical Genitourinary Cancer|April 14, 2024
NLR Outperforms Low Hemoglobin and High Platelet Count as Predictive and Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsMatthew Young, Jose C Tapia, Bernadett Szabados, et al.International Journal of Cancer|February 7, 2026
International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and PortugalJose C Tapia, Javier Gavira, Diana Matthews, et al.Clinical Genitourinary Cancer|March 2, 2024
Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021Jose C Tapia, Freya Bosma, Javier Gavira, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 29, 2024
Cumulative incidences of hypogonadism, hypertension, and dyslipidaemia in patients with stage I seminoma treated with a risk-adapted strategy: a Spanish single-centre retrospective analysisJose C Tapia, Javier Gavira, Georgia Anguera, et al.European Journal of Cancer (Oxford, England : 1990)|April 4, 2025
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, et al.Cancers|September 14, 2024
The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 DiseaseElia Seguí, Juan Manuel Torres, Edouard Auclin, et al.Pageof 1